Concepedia

Shenglong Li

SL

Statistics

Publications

5

Citations

131

H-Index

5

Active since

2017

Affiliations

Liaoning Cancer Hospital & Institute(Current)

Dalian Medical University

China Medical University

Shenglong Li is an author at Liaoning Cancer Hospital & Institute specializing in oncology, medicine, and parathyroid hormone-related protein signaling.

ORCID

Publications per year

2017–2021

5

Publications

5

Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants

Tingting Li, Xiaojian Han, Chenjian Gu et al. · Nature Communications · 2021 · 50 citations · Full text

, , +14

Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma

Shenglong Li, Yuyuan Xiong, Xiaojing Zhang · Biomedicine & Pharmacotherapy · 2017 · 36 citations

, , +16

Treatment and outcome prognosis of patients with high-energy transsyndesmotic ankle fracture dislocation—the “Logsplitter” injury

Zhe Wang, Xin Tang, Shenglong Li et al. · Journal of Orthopaedic Surgery and Research · 2017 · 22 citations · Full text

, , +17

β-Alanine mediated inhibition of PTHR1suppresses the proliferation, invasion and tumorigenesis in metastatic human osteosarcoma U2OS cells

Shenglong Li, Peng Chen, Ke Zheng et al. · International Journal of Biological Macromolecules · 2018 · 12 citations

, , +12

Transcriptomic analyses reveal the underlying pro-malignant functions of PTHR1 for osteosarcoma via activation of Wnt and angiogenesis pathways

Shenglong Li, Yujin Dong, Ke Wang et al. · Journal of Orthopaedic Surgery and Research · 2017 · 11 citations · Full text

, , +16

1–5 of 5